Updates in Urologic Oncology
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.
When it comes to defeating cancer, Fox Chase Cancer Center never rests on its laurels. Every day, Fox Chase faculty, fellows, and residents discover innovative, life-enhancing therapies for deadly cancers and deliver care in the most compassionate ...
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
Join us for this in-person educational program, presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced ...
Alexander Kutikov, MD, FACS Moderator
Daniel M. Geynisman, MD Moderator
The Phase III randomized trial compares Bacillus Calmette-Guerin (BCG) immunotherapy, the standard-of-care intravesical treatment for high grade non-muscle invasive bladder cancer, versus intravesical Docetaxel and Gemcitabine treatment in BCG naïve patients.
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The Fox Chase genitourinary oncology team cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
Tackling Anything Patients Need Before, During, and After Urologic Surgery
Growing up, Mary Ellen Day was athletic and focused—dreaming that one day, she would become a ‘real’ cheerleader.
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black ...
Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.